KIT and Miyoshi myopathy: In contrast to non-acral cutaneous melanoma, AM and MM tumors show frequent activation of KIT (Curtin, Busam, Pinkel, & Bastian, 2006; Hayward et al., 2017), and monotherapy targeting the c-KIT RTK is a potential treatment.